Creon DR 36,000 unit capsule UU 100S
Ended Awarded
- Contract number
- SPE2DR26F7XQT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,424
Award facts
- Contract value 100% obligated
- $10,423.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $10,423.59 delivery order to Amerisourcebergen Drug Corp on June 3, 2026, for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) with an ultimate completion date of June 4, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside applied. This delivery order is issued under a DLA Troop Support Medical indefinite delivery contract supporting pharmaceutical supply to military healthcare facilities.
Quick answers
Who was awarded contract SPE2DR26F7XQT?
SPE2DR26F7XQT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 3, 2026.
How much is contract SPE2DR26F7XQT worth?
The government has obligated $10,424 on SPE2DR26F7XQT.
Is contract SPE2DR26F7XQT an order under another contract?
Yes. SPE2DR26F7XQT is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7XQT competed?
The extent of competition for SPE2DR26F7XQT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award